Clinical Trial Update: Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability update of SNS-314 in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SNS-314

Snippet

Sponsor: Sunesis Pharmaceuticals | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED